The burden of diabetes in America: a data-driven analysis using power BI

Authors

  • Onyeka Chukwudalu Ekwebene Department of Biostatistics and Epidemiology, East Tennessee State University, Johnson City, Tennessee, United States of America
  • Ngozi Veronica Umeanowai Department of Computing, East Tennessee State University, United States of America
  • Gabriel Chidera Edeh Nnamdi Azikiwe University, Awka, Anambra State, Nigeria
  • Gideon Ugbeyo Noah Department of Biostatistics and Epidemiology, East Tennessee State University, Johnson City, Tennessee, United States of America
  • Adetayo Folasole Department of Computing, East Tennessee State University, United States of America
  • Olajide J. Olagunju Division of Infectious Disease, Case Western Reserve University, School of Medicine, Cleveland Ohio, United States of America
  • Somtochukwu Abazu College of Public Health, University of South Florida, Tampa, United States of America

DOI:

https://doi.org/10.18203/2320-6012.ijrms20240203

Keywords:

Diabetes, Health care, Metabolic disease, Prediabetes, Prevalence

Abstract

Background: High blood glucose levels in diabetes lead to devastating damage to the heart, blood vessels, eyes, kidneys, and nerves. It affects millions of Americans and costs the healthcare system billions of dollars. The disease’s causes, risk factors, and effective prevention and treatment methods are still unknown despite its prevalence.

Methods: This descriptive study used US census and CDC data to describe diabetes in America. The US census and CDC provided this study’s population and diabetes data. This study used two datasets. The first dataset contains 73054 2020 US population records. This dataset’s second type was strings and decimals, including state, county, and 2020 affected population percentage. Diabetics are represented by 3154 data points. Power BI was used to visualize decision support data.

Results: According to our analysis, millions of Americans suffer from diabetes, which costs billions in healthcare costs annually. Diabetes is most prevalent in California, with 28.9 million people affected. Most cases are 45-64 years old, and the number has increased over the past decade. These findings suggest that America’s growing diabetes epidemic requires more resources and facilities.

Conclusions: Finally, our study covers diabetes’s prevalence, incidence, and trends in America. Our findings show that America’s growing diabetes epidemic need more money, manpower, and infrastructure. We advise the government to monitor diabetes and plan for future healthcare needs.

References

Global Diabetes Summit. Geneva: World Health Organization; 2021. Available from: https://www.who.int/news-room/events/detail/2021/04/14/default-calendar/global-diabetes-summit. Accessed on 7 June 2023.

Centers for Disease Control and Prevention. Prediabetes- Your Chance to Prevent Type 2 Diabetes. 2022. Available from: https://www.cdc.gov/diabetes/basics/prediabetes.html. Accessed on 8 December 2023.

Fang L, Zhang Q. Research progress in improving insulin resistance of type 2 diabetes mellitus with traditional Chinese medicine. Lishizhen Med Materia Med Res. 2017;28:2974-6.

Brown DM, Tuomi L, Shapiro H, Pier Study Group. Anatomical measures as predictors of visual outcomes in ranibizumab-treated eyes with neovascular age-related macular degeneration. Retina. 2013;33(1):23-34.

Diabetes Research Institute: Diabetes Statistics. Available from: https://diabetesresearch.org/ diabetes-statistics/. Accessed on 7 June 2023.

American Diabetes Association (ADA): Statistics about Diabetes. Available from: https://diabetes.org/about-diabetes/statistics/about-diabetes#:~:text=Diagnosed%20and%20undiagnosed%3A%20Of%20the,seniors%20(diagnosed%20and%20undiagnosed). Accessed on 7 June 2023.

Si D, Bailie R, Wang Z, Weeramanthri T. Comparison of diabetes management in five countries for general and indigenous populations: an internet-based review. BMC Health Serv Res. 2010;10(1):1-9.

World Health Statistics. (2016). Available from: https://search.yahoo.com/search?fr=mcafee&type=E211US105G0&p=World+Health+Statistics+2014. +Geneva%3A+World+Health+Org. Accessed on 11 December 2023.

Whicher CA, O'Neill S, Holt RIG. Diabetes in the UK: 2019. Diabetes Med. 2020;37(2):242-7.

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda BI. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-81.

Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778-86.

Yang JJ, Yu D, Wen W, Saito E, Rahman S, Shu XO, et al. Association of diabetes with all-cause and cause-specific mortality in Asia: a pooled analysis of more than 1 million participants. JAMA Network Open. 2019;2(4):e192696.

Bragg F, Holmes MV, Iona A, Guo Y, Du H, Chen Y, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA. 2017;317(3):280-9.

Downloads

Published

2024-01-30

How to Cite

Ekwebene, O. C., Umeanowai, N. V., Edeh, G. C., Noah, G. U., Folasole, A., Olagunju, O. J., & Abazu, S. (2024). The burden of diabetes in America: a data-driven analysis using power BI. International Journal of Research in Medical Sciences, 12(2), 392–396. https://doi.org/10.18203/2320-6012.ijrms20240203

Issue

Section

Original Research Articles